Literature DB >> 2945831

Heinz bodies induce clustering of band 3, glycophorin, and ankyrin in sickle cell erythrocytes.

S M Waugh, B M Willardson, R Kannan, R J Labotka, P S Low.   

Abstract

In earlier model studies we demonstrated that artificially denatured hemoglobin binds to and clusters the protein, band 3, in the plane of the erythrocyte membrane. To determine whether denatured hemoglobin also clusters band 3 in vivo, we have compared the locations of denatured hemoglobin aggregates (Heinz bodies) with band 3 in sickle cells using phase contrast and immunofluorescence microscopy. We report that where Heinz bodies are found associated with the cytoplasmic surface of the membrane, clusters of band 3 are usually colocalized within the membrane. In contrast, normal erythrocyte membranes and regions of sickle cell membranes devoid of Heinz bodies display an uninterrupted staining of band 3. Similarly, ankyrin and glycophorin are periodically seen to aggregate at Heinz body sites, but the degree of colocalization is lower than for band 3. These data demonstrate that the binding of denatured hemoglobin to the membrane forces a redistribution of several major membrane components.

Mesh:

Substances:

Year:  1986        PMID: 2945831      PMCID: PMC423798          DOI: 10.1172/JCI112696

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Purification of two spectrin-binding proteins: biochemical and electron microscopic evidence for site-specific reassociation between spectrin and bands 2.1 and 4.1.

Authors:  J M Tyler; W R Hargreaves; D Branton
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

2.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

3.  Erythrocyte catabolism by macrophages in vitro: dissociation of phagocytosis and heme oxygenase induction.

Authors:  D Gemsa; H H Fudenberg; R Schmid
Journal:  Trans Assoc Am Physicians       Date:  1972

4.  Human erythrocyte ankyrin. Purification and properties.

Authors:  V Bennett; P J Stenbuck
Journal:  J Biol Chem       Date:  1980-03-25       Impact factor: 5.157

5.  Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease.

Authors:  R P Hebbel; O Yamada; C F Moldow; H S Jacob; J G White; J W Eaton
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

6.  Covalent labelling of specific membrane carbohydrate residues with fluorescent probes.

Authors:  G Abraham; P S Low
Journal:  Biochim Biophys Acta       Date:  1980-04-10

7.  Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells.

Authors:  S E Lux; K M John; M J Karnovsky
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

8.  Irreversibly sickled cells and red cell survival in sickle cell anemia: a study with both DF32P and 51CR.

Authors:  P R McCurdy; A S Sherman
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

9.  Calcium-induced damage of haemoglobin SS and normal erythrocytes.

Authors:  J W Eaton; E Berger; J G White; H S Jacob
Journal:  Br J Haematol       Date:  1978-01       Impact factor: 6.998

10.  Interactions of haemoglobin with erythrocyte membrane phospholipids in monomolecular lipid layers.

Authors:  I Szundi; J G Szelényi; J H Breuer; A Bérczi
Journal:  Biochim Biophys Acta       Date:  1980
View more
  18 in total

1.  Lateral diffusion and aggregation. A Monte Carlo study.

Authors:  M J Saxton
Journal:  Biophys J       Date:  1992-01       Impact factor: 4.033

2.  Nanoscale dielectrophoretic spectroscopy of individual immobilized mammalian blood cells.

Authors:  Brian P Lynch; Al M Hilton; Garth J Simpson
Journal:  Biophys J       Date:  2006-06-23       Impact factor: 4.033

3.  Membrane peroxidation and methemoglobin formation are both necessary for band 3 clustering: mechanistic insights into human erythrocyte senescence.

Authors:  Nobuto Arashiki; Naoki Kimata; Sumie Manno; Narla Mohandas; Yuichi Takakuwa
Journal:  Biochemistry       Date:  2013-08-16       Impact factor: 3.162

4.  Oxidation of hemoglobin and redistribution of band 3 promote erythrophagocytosis in visceral leishmaniasis.

Authors:  Sudipa Saha Roy; Kaustav Dutta Chowdhury; Gargi Sen; Tuli Biswas
Journal:  Mol Cell Biochem       Date:  2008-09-06       Impact factor: 3.396

5.  Membrane protein lesions in erythrocytes with Heinz bodies.

Authors:  O S Platt; J F Falcone
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  Red blood cell clearance in inflammation.

Authors:  Marleen Straat; Robin van Bruggen; Dirk de Korte; Nicole P Juffermans
Journal:  Transfus Med Hemother       Date:  2012-09-06       Impact factor: 3.747

7.  Band 3 and glycophorin are progressively aggregated in density-fractionated sickle and normal red blood cells. Evidence from rotational and lateral mobility studies.

Authors:  J D Corbett; D E Golan
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

8.  Sickle hemoglobin disturbs normal coupling among erythrocyte O2 content, glycolysis, and antioxidant capacity.

Authors:  Stephen C Rogers; Jerlinda G C Ross; Andre d'Avignon; Lindsey B Gibbons; Vered Gazit; Mojibade N Hassan; Dylan McLaughlin; Sherraine Griffin; Tara Neumayr; Malcolm Debaun; Michael R DeBaun; Allan Doctor
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

9.  Modulation of nitric oxide bioavailability by erythrocytes.

Authors:  K T Huang; T H Han; D R Hyduke; M W Vaughn; H Van Herle; T W Hein; C Zhang; L Kuo; J C Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

10.  Red cell membrane remodeling in sickle cell anemia. Sequestration of membrane lipids and proteins in Heinz bodies.

Authors:  S C Liu; S J Yi; J R Mehta; P E Nichols; S K Ballas; P W Yacono; D E Golan; J Palek
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.